Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001784077 | SCV002018079 | pathogenic | not provided | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002544279 | SCV003455487 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-02-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1325402). This premature translational stop signal has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 17236769). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu206Argfs*14) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). |
Fulgent Genetics, |
RCV005006052 | SCV005635663 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A; Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2024-02-21 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475093 | SCV004211570 | likely pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2023-09-07 | flagged submission | clinical testing |